FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to rheumatology, and can be used to assess the risk of sacroiliitis progression in early forms of psoriatic arthritis. Presence and scoring of dactylitis, the severity of the psoriatic skin lesion based on the BSA value, the presence of nail psoriasis, the CRP level in mg/l, the presence of TNF-α with subsequent determination of risk of sacroiliitis progression by formula. And if the risk of sacroiliitis progression is more than or equal to 4.729, the patient is referred to a group with a high risk of sacroiliitis progression.
EFFECT: method enables determining the probability of a risk of spinal involvement at an early stage of the disease, selecting the most optimal therapeutic approach and preventing the progression of spondylyitis and the development of irreversible structural changes by assessing the most significant values.
1 cl, 1 dwg, 1 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR ASSESSING THE RISK OF JOINT EROSIONS IN PATIENTS WITH PSORIATIC ARTHRITIS | 2022 |
|
RU2791661C1 |
METHOD FOR RAPID ASSESSMENT OF AXIAL SKELETON INVOLVEMENT RISK IN EARLY FORMS OF PSORIATIC ARTHRITIS | 2020 |
|
RU2724276C1 |
METHOD FOR ASSESSING POSSIBILITY OF ACHIEVING MINIMUM DISEASE ACTIVITY IN PATIENTS WITH PSORIATIC ARTHRITIS | 2024 |
|
RU2829416C1 |
METHOD FOR DETERMINING INDICATIONS TO BEGINNING OF RECEPTION OF GENETIC ENGINEERING BIOLOGICAL PREPARATIONS WITH INEFFECTIVENESS OF BASIC ANTI-INFLAMMATORY PREPARATIONS IN EARLY FORMS OF PSORIATIC ARTHRITIS | 2020 |
|
RU2731807C1 |
METHOD FOR DETERMINING PSORIATIC ARTHRITIS ACTIVITY | 2020 |
|
RU2746884C1 |
METHOD FOR PREDICTION OF ACHIEVING AN ACCEPTABLE QUALITY OF LIFE IN PSORIATIC ARTHRITIS | 2024 |
|
RU2837142C1 |
METHOD OF PREDICTING ACHIEVEMENT OF MINIMAL DISEASE ACTIVITY DURING THERAPY IN TREATMENT OF PATIENTS WITH PSORIATIC ARTHRITIS | 2022 |
|
RU2808550C1 |
METHOD FOR ASSESSING THE EFFECTIVENESS OF TREATMENT OF PSORIATIC ARTHRITIS USING OXIDATIVE STRESS PARAMETERS | 2021 |
|
RU2762104C1 |
USE OF IL-17 ANTAGONISTS FOR INHIBITION OF STRUCTURAL DAMAGE PROGRESSION IN PATIENTS WITH PSORIATIC ARTHRITIS | 2015 |
|
RU2697383C2 |
METHOD FOR PSORIATIC ARTHRITIS DIAGNOSTICS | 2016 |
|
RU2629627C1 |
Authors
Dates
2025-03-26—Published
2024-09-24—Filed